Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
15.55
-0.32 (-2.02%)
Sep 23, 2026, 4:00 PM EDT - Market closed
AAPG Market Cap
AAPG has a market cap or net worth of $1.45 billion as of September 23, 2026. Its market cap has decreased by -59.28% in one year.
Market Cap
1.45B
Enterprise Value
1.48B
1-Year Change
-59.28%
Ranking
Category
Stock Price
$15.55
ChartMarket Cap Chart
Since the IPO on January 24, 2025, AAPG's market cap has decreased from $1.48B to $1.45B, a decrease of -2.25%. That is a compound annual growth rate of -1.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 1.45B | -41.31% |
| Dec 31, 2025 | 2.47B | 66.57% |
| Jan 24, 2025 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ultragenyx Pharmaceutical | 1.43B |
| ArriVent BioPharma | 1.42B |
| Alpha Tau Medical | 1.41B |
| Avalyn Pharma | 1.40B |
| Damora Therapeutics | 1.39B |
| First Tracks Biotherapeutics | 1.38B |
| LB Pharmaceuticals | 1.37B |
| Savara | 1.36B |